<DOC>
	<DOC>NCT00466622</DOC>
	<brief_summary>FlowMet study is a "sub-study" of the PregMet study (registered in 2005). The aim of the FlowMet study is to register the possible effect of metformin on the blood flow of the uterine artery in pregnant PCOS women. The participants will be examined with ultrasound Doppler in gestational week 10-13: 1. before and 3h after the first tablet intake of metformin/placebo 2. and 10-14 days after inclusion in the trial 3. blood flow in the umbilical artery and fetal cerebral artery in gestational week 24.</brief_summary>
	<brief_title>Uterine Artery Blood Flow in Pregnant Women With PCOS Treated With Metformin</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Same as in the PregMet study. As this study is a substudy/extended study of the PregMet study, ONLY those included in the PregMet study (NCT00159536) can participate. Same as in the PregMet study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>PCOS</keyword>
	<keyword>pregnancy</keyword>
	<keyword>metformin</keyword>
	<keyword>blood flow</keyword>
	<keyword>Pulsatility index</keyword>
</DOC>